スポンサーリンク
Second Department Of Medicine Nihon University School Of Medicine | 論文
- Randomized comparison of vasopressin and epinephnine in patients out-of-hospital cardiac arrest
- IS111 Chalamydia Pneumoniae Acute Infection as a Trigger of Coronary Plaque Rapture in Patients With Acute Coronary Syndorome
- Calcium Channel Blockers Shorten the Periodicity of Ultradian Variation in Blood Pressure in Patients with Essential Hypertension
- Involvement of Inflammation in Acute Coronary Syndromes Assessed by Levels of High-Sensitivity C-Reactive Protein, Matrix Metalloproteinase-9 and Soluble Vascular-Cell Adhesion Molecule-1
- Vasopressin as Compared with Epinephrine for Out-of-Hospital Cardiac Arrest
- Antithrombin-3 (AT-3) as a Marker of Thrombolytic Therapy Using Mutant t-PA in Patients with Acute Myocardial Infarction (AMI)
- The Diagnostic Value of D-Dimer in Patients with Acute Aortic Dissection (AAD)
- Keynote Lecture : Reperfusion Strategy for Acute Myocardial Infarction Using Fibrinolysis and Subsequent Transluminal Therapy : FAST Trial
- Regulation of Arginine Vasopressin in the Human Heart
- Relation of Secretory Phospholipase A_2 and High-Sensitivity C-Reactive Protein to Chlamydia Pneumoniae Infection in Acute Coronary Syndromes
- 6 Infection and Arteriosclerosis(Plenary Session 2 (PL2) (IHD) : Inflammation and Atherosclerosis : From Bench to Bedside)(Special Program)
- Infection With Chlamydia pneumoniae Increases Neointimal Formation After Injury and Treatment With Clarithromycin Prevents It in a Murine Model
- The vasoactive mediators in patients with shock and hypotension due to volume, pump and rate problems
- Drinking Green Tea Reduces Atherosclerotic Lesion Formation in Hypercholesterolemic ApoE(-/-) Mice
- Increased type II Phospholipase A2 Concentrations in Patients with ACS : Correlation with High Sensitive C-Reactive Protein and Chlamydia pneumoniae antibody
- Infection with Chlamydia pneumoniae within Vulnerable Plaque of Coronary Artery in Patients with Acute Coronary Syndrome
- Should insulin resistance be treated to nondiabetic patients?